Nathan Joseph Silva Godinho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nathan Joseph Silva Godinho has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Marco Antonio Andrade
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
4 shared publications - Caio Hernandes Colhado
Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil
3 shared publications - Marcos Antonio Dias Vilela
Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil
3 shared publications - Lucas Guimarães Campos Roriz de Amorim
Department of Urology, Indiana University, Indianapolis, USA
2 shared publications - Alec Anceno
Department of Urology, University of Southern California, Los Angeles, USA
1 shared publication - Alejandro Bautista-Pérez-Gavilán
Instituto Nacional de Cardiología Ignacio Chávez
1 shared publication
Latest Publications
- 10 November 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 797
Diagnostic yield and early outcomes of radical prostatectomy without prior histopathologic diagnosis: a single-arm systematic review and meta-analysis
- 10 November 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 797
Diagnostic yield and early outcomes of radical prostatectomy without prior histopathologic diagnosis: a single-arm systematic review and meta-analysis
- 24 August 2026
- Published by Springer Nature in International Urology and Nephrology
- p. 1-21
Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis of randomized controlled trials at 12 months
Purpose This network meta-analysis evaluates efficacy outcomes of established and emerging techniques to inform evidence-based clinical decision-making. Materials and methods PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials comparing minimally invasive treatments for benign prostatic hyperplasia. Primary outcomes encompassed urinary function, sexual function, safety, and durability. Network meta-analysis was conducted using MetaInsight. Results Among 36 randomized controlled trials and 4851 patients, no individual intervention significantly outperformed bTURP in either symptom control, peak urinary flow, hospital stay, complications, or medical retreatment at 12 months. PUL was the only technique significantly inferior to bTURP in bladder emptying (PVR: MD 67.47 mL; 95% CrI 11.02–125.79), yet demonstrated superior ejaculatory function preservation over mTURP/bTURP (MSHQ-EjD: MD 4.99; 95% CrI 1.32–8.64) without differences in ejaculatory bother. HoLEP showed significantly lower surgical retreatment rates versus bTURP and mTURP, and HoLEP and ThuLEP demonstrated shorter catheterization times versus bTURP (MD −36.26 h and −26.89 h, respectively). When grouped by category, stent/implant devices were significantly inferior to enucleation, ablation, and resection in urinary outcomes, yet demonstrated superior ejaculatory function preservation versus resection (MSHQ-EjD: MD 5.01; 95% CrI 1.33–8.65) without differences in ejaculatory bother. Enucleation was the only category with significantly reduced surgical retreatment versus sham. Conclusions No intervention surpassed bTURP in urinary efficacy. HoLEP demonstrated superior durability, while stent/implant approaches and PUL showed inferior urinary outcomes. Preservation of ejaculatory function with stent/implant techniques did not translate into reduced patient-reported bother.
- 24 August 2026
- Published by Springer Nature in International Urology and Nephrology
- p. 1-21
Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis of randomized controlled trials at 12 months
Purpose This network meta-analysis evaluates efficacy outcomes of established and emerging techniques to inform evidence-based clinical decision-making. Materials and methods PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials comparing minimally invasive treatments for benign prostatic hyperplasia. Primary outcomes encompassed urinary function, sexual function, safety, and durability. Network meta-analysis was conducted using MetaInsight. Results Among 36 randomized controlled trials and 4851 patients, no individual intervention significantly outperformed bTURP in either symptom control, peak urinary flow, hospital stay, complications, or medical retreatment at 12 months. PUL was the only technique significantly inferior to bTURP in bladder emptying (PVR: MD 67.47 mL; 95% CrI 11.02–125.79), yet demonstrated superior ejaculatory function preservation over mTURP/bTURP (MSHQ-EjD: MD 4.99; 95% CrI 1.32–8.64) without differences in ejaculatory bother. HoLEP showed significantly lower surgical retreatment rates versus bTURP and mTURP, and HoLEP and ThuLEP demonstrated shorter catheterization times versus bTURP (MD −36.26 h and −26.89 h, respectively). When grouped by category, stent/implant devices were significantly inferior to enucleation, ablation, and resection in urinary outcomes, yet demonstrated superior ejaculatory function preservation versus resection (MSHQ-EjD: MD 5.01; 95% CrI 1.33–8.65) without differences in ejaculatory bother. Enucleation was the only category with significantly reduced surgical retreatment versus sham. Conclusions No intervention surpassed bTURP in urinary efficacy. HoLEP demonstrated superior durability, while stent/implant approaches and PUL showed inferior urinary outcomes. Preservation of ejaculatory function with stent/implant techniques did not translate into reduced patient-reported bother.
- Open Access
- 1 April 2026
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 52 (2)
Impact of Preoperative Silodosin on Ureteroscopy Outcomes for Ureterolithiasis: A Systematic Review and Meta-Analysis
Purpose: To perform a systematic review and meta-analysis evaluating the efficacy and safety of preoperative silodosin in improving ureteroscopy (URS) outcomes for ureterolithiasis. Materials and Methods: PubMed, EMBASE and Cochrane Central were systematically searched for studies comparing preoperative silodosin with placebo or ‘no preoperative silodosin’ in patients undergoing URS for ureteral stones. Primary outcomes included ureteral wall injury, analgesia use, fever, haematuria, stone-free rate (SFR), operative time, and complications. Statistical analysis was performed using Review Manager 5.1.7. Study quality and risk of bias were assessed per Cochrane guidelines. Results: Nine studies, including eight randomized clinical trials, including 960 patients were analysed; 450 (46.8%) received silodosin. Compared to controls, silodosin significantly reduced ureteral injuries (RR 0.30; 95% CI: 0.18–0.49; p < 0.00001) and operative time (MD −17.72 minutes; 95% CI: −24.72 to −10.72; p < 0.00001). It also lowered analgesia needs (RR 0.35; 95% CI: 0.16–0.75; p = 0.007), with trends toward reduced fever (RR 0.67; 95% CI: 0.36–1.22; p = 0.19) and haematuria (RR 0.57; 95% CI: 0.32–1.02; p = 0.06). In studies with ≥10 days of preoperative use, silodosin significantly improved SFR (RR 1.17; 95% CI: 1.10–1.26; p < 0.00001). Conclusions: Preoperative silodosin reduces ureteral injuries, operative time, and complications, supporting its use to improve safety and efficiency of URS for ureterolithiasis.
- 1 April 2026
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 52 (2)
Open AccessImpact of Preoperative Silodosin on Ureteroscopy Outcomes for Ureterolithiasis: A Systematic Review and Meta-Analysis
Purpose: To perform a systematic review and meta-analysis evaluating the efficacy and safety of preoperative silodosin in improving ureteroscopy (URS) outcomes for ureterolithiasis. Materials and Methods: PubMed, EMBASE and Cochrane Central were systematically searched for studies comparing preoperative silodosin with placebo or ‘no preoperative silodosin’ in patients undergoing URS for ureteral stones. Primary outcomes included ureteral wall injury, analgesia use, fever, haematuria, stone-free rate (SFR), operative time, and complications. Statistical analysis was performed using Review Manager 5.1.7. Study quality and risk of bias were assessed per Cochrane guidelines. Results: Nine studies, including eight randomized clinical trials, including 960 patients were analysed; 450 (46.8%) received silodosin. Compared to controls, silodosin significantly reduced ureteral injuries (RR 0.30; 95% CI: 0.18–0.49; p < 0.00001) and operative time (MD −17.72 minutes; 95% CI: −24.72 to −10.72; p < 0.00001). It also lowered analgesia needs (RR 0.35; 95% CI: 0.16–0.75; p = 0.007), with trends toward reduced fever (RR 0.67; 95% CI: 0.36–1.22; p = 0.19) and haematuria (RR 0.57; 95% CI: 0.32–1.02; p = 0.06). In studies with ≥10 days of preoperative use, silodosin significantly improved SFR (RR 1.17; 95% CI: 1.10–1.26; p < 0.00001). Conclusions: Preoperative silodosin reduces ureteral injuries, operative time, and complications, supporting its use to improve safety and efficiency of URS for ureterolithiasis.
- Open Access
- 12 January 2026
- Published by Springer Nature in African Journal of Urology
- Vol. 32 (1) , 2
A comparison of prostate cancer detection rates between TRUS-GB and MRI-GB: a systematic review and meta-analysis
Background: Prostate cancer (PCa) is one of the most common cancers in men and a major cause of cancer-related death. Accurate diagnosis is essential to identify clinically significant cases while avoiding overdiagnosis. Traditionally, prostate biopsies are performed as systematic sampling using transrectal ultrasound guidance (systematic TRUS-GB), whereas lesion-targeted multiparametric magnetic resonance imaging–guided biopsy (lesion-targeted mpMRI-GB) has emerged as a promising alternative. While lesion-targeted mpMRI-GB may improve cancer detection, its clinical advantage over systematic TRUS-GB remains debated. This meta-analysis compares the detection rates of PCa between lesion-targeted mpMRI-GB and systematic TRUS-GB in biopsy-naive patients. Main body: We systematically searched PubMed, Cochrane Central, Scielo, and LILACS for studies comparing lesion-targeted mpMRI-GB to systematic TRUS-GB in biopsy-naive patients suspected of having PCa. Outcomes included the detection rate of overall PCa, clinically significant PCa, clinically insignificant PCa, and missed diagnoses. We included 9,165 patients from 14 studies, of which three were randomized controlled trials (RCTs). lesion-targeted mpMRI-GB was used to diagnose overall PCa in 4,349 (47,45%) patients. The cancer detection rate of overall PCa (RR 1.26; 95% CI 1.02–1.55; p < 0.00001; i² = 95%) and clinically significant PCa (RR 1.46; 95% CI 1.11–1.93; p = 0.007; i² = 93%) were significantly higher in patients diagnosed with lesion-targeted mpMRI-GB. The detection rate of clinically insignificant cancer (RR 0.85; CI 0.64–1.13; p = 0.25; I² = 77%) was not statistically significant. However, missed diagnoses were lower in the systematic TRUS-GB group, showing a potential difference. Subgroup analysis was evaluated. Conclusions: Using lesion-targeted mpMRI-GB as a first-line approach increases the likelihood of detecting clinically significant prostate cancer. However, lesion-targeted mpMRI-GB has not demonstrated clear superiority over systematic TRUS-GB in reducing missed diagnoses, suggesting that the choice of technique should be individualized or that a combined biopsy strategy may be considered.
- 12 January 2026
- Published by Springer Nature in African Journal of Urology
- Vol. 32 (1) , 2
Open AccessA comparison of prostate cancer detection rates between TRUS-GB and MRI-GB: a systematic review and meta-analysis
Background: Prostate cancer (PCa) is one of the most common cancers in men and a major cause of cancer-related death. Accurate diagnosis is essential to identify clinically significant cases while avoiding overdiagnosis. Traditionally, prostate biopsies are performed as systematic sampling using transrectal ultrasound guidance (systematic TRUS-GB), whereas lesion-targeted multiparametric magnetic resonance imaging–guided biopsy (lesion-targeted mpMRI-GB) has emerged as a promising alternative. While lesion-targeted mpMRI-GB may improve cancer detection, its clinical advantage over systematic TRUS-GB remains debated. This meta-analysis compares the detection rates of PCa between lesion-targeted mpMRI-GB and systematic TRUS-GB in biopsy-naive patients. Main body: We systematically searched PubMed, Cochrane Central, Scielo, and LILACS for studies comparing lesion-targeted mpMRI-GB to systematic TRUS-GB in biopsy-naive patients suspected of having PCa. Outcomes included the detection rate of overall PCa, clinically significant PCa, clinically insignificant PCa, and missed diagnoses. We included 9,165 patients from 14 studies, of which three were randomized controlled trials (RCTs). lesion-targeted mpMRI-GB was used to diagnose overall PCa in 4,349 (47,45%) patients. The cancer detection rate of overall PCa (RR 1.26; 95% CI 1.02–1.55; p < 0.00001; i² = 95%) and clinically significant PCa (RR 1.46; 95% CI 1.11–1.93; p = 0.007; i² = 93%) were significantly higher in patients diagnosed with lesion-targeted mpMRI-GB. The detection rate of clinically insignificant cancer (RR 0.85; CI 0.64–1.13; p = 0.25; I² = 77%) was not statistically significant. However, missed diagnoses were lower in the systematic TRUS-GB group, showing a potential difference. Subgroup analysis was evaluated. Conclusions: Using lesion-targeted mpMRI-GB as a first-line approach increases the likelihood of detecting clinically significant prostate cancer. However, lesion-targeted mpMRI-GB has not demonstrated clear superiority over systematic TRUS-GB in reducing missed diagnoses, suggesting that the choice of technique should be individualized or that a combined biopsy strategy may be considered.
- Open Access
Comparative Outcomes of Laparoscopic Fundoplication and Magnetic Sphincter Augmentation for GERD: A Systematic Review and Meta-Analysis
Introduction: Patients with gastroesophageal reflux disease (GERD) who fail conservative therapy often undergo surgical intervention. While laparoscopic fundoplication (LF) is considered the standard procedure, the Magnetic Sphincter Augmentation (MSA) system has emerged as a promising alternative. Debate remains regarding their comparative effectiveness and safety. Methods: This systematic review and meta-analysis examined studies comparing MSA to LF for GERD. We searched PubMed, Cochrane Central, and Embase databases using a comprehensive search strategy with multiple combinations of Medical Subject Headings (MeSH) terms and keywords related to gastroesophageal reflux disease, magnetic sphincter augmentation, LINX device, and fundoplication procedures. Key endpoints included symptom relief, quality of life, complications, recurrence, reoperation, and patient satisfaction. Studies were included if they were published in English, compared MSA (LINX Reflux Management System) with LF in patients diagnosed with GERD, and reported comparative outcomes. We excluded animal studies, case reports, case series, studies without relevant comparative data, and those with overlapping populations. Two independent reviewers screened studies using Rayyan software, with discrepancies resolved by a third reviewer. Data extraction was performed systematically using a standardized form, and quality assessment was conducted using the ROBINS-I tool for non-randomized studies. Meta-analysis was performed using random-effects models with risk ratios for dichotomous outcomes and standardized mean differences for continuous outcomes. Results: Twelve studies, involving 11,690 patients (2,009 MSA; 9,681 LF), met inclusion criteria. MSA demonstrated significantly shorter operative times and hospital stays. Rates of postoperative complications, dysphagia, patient satisfaction, and reoperation did not differ significantly between groups. While both treatments provided comparable symptom control, MSA patients reported fewer gas and bloating issues, better ability to belch, and maintained the ability to vomit. There was no clear superiority of MSA over LF in terms of completely discontinuing proton pump inhibitors, although a slight trend favored MSA. Conclusion: MSA and LF offer broadly similar outcomes for GERD, with no significant differences in safety, reoperation rates, and overall patient satisfaction. However, MSA may confer advantages in reducing operative times, hospital stays, gas-related symptoms, and preserving physiological functions such as belching and vomiting. These findings support the role of MSA as a viable alternative to LF, but further randomized controlled trials are needed to strengthen the evidence base and assist clinicians in tailored decision-making.
Open AccessComparative Outcomes of Laparoscopic Fundoplication and Magnetic Sphincter Augmentation for GERD: A Systematic Review and Meta-Analysis
Introduction: Patients with gastroesophageal reflux disease (GERD) who fail conservative therapy often undergo surgical intervention. While laparoscopic fundoplication (LF) is considered the standard procedure, the Magnetic Sphincter Augmentation (MSA) system has emerged as a promising alternative. Debate remains regarding their comparative effectiveness and safety. Methods: This systematic review and meta-analysis examined studies comparing MSA to LF for GERD. We searched PubMed, Cochrane Central, and Embase databases using a comprehensive search strategy with multiple combinations of Medical Subject Headings (MeSH) terms and keywords related to gastroesophageal reflux disease, magnetic sphincter augmentation, LINX device, and fundoplication procedures. Key endpoints included symptom relief, quality of life, complications, recurrence, reoperation, and patient satisfaction. Studies were included if they were published in English, compared MSA (LINX Reflux Management System) with LF in patients diagnosed with GERD, and reported comparative outcomes. We excluded animal studies, case reports, case series, studies without relevant comparative data, and those with overlapping populations. Two independent reviewers screened studies using Rayyan software, with discrepancies resolved by a third reviewer. Data extraction was performed systematically using a standardized form, and quality assessment was conducted using the ROBINS-I tool for non-randomized studies. Meta-analysis was performed using random-effects models with risk ratios for dichotomous outcomes and standardized mean differences for continuous outcomes. Results: Twelve studies, involving 11,690 patients (2,009 MSA; 9,681 LF), met inclusion criteria. MSA demonstrated significantly shorter operative times and hospital stays. Rates of postoperative complications, dysphagia, patient satisfaction, and reoperation did not differ significantly between groups. While both treatments provided comparable symptom control, MSA patients reported fewer gas and bloating issues, better ability to belch, and maintained the ability to vomit. There was no clear superiority of MSA over LF in terms of completely discontinuing proton pump inhibitors, although a slight trend favored MSA. Conclusion: MSA and LF offer broadly similar outcomes for GERD, with no significant differences in safety, reoperation rates, and overall patient satisfaction. However, MSA may confer advantages in reducing operative times, hospital stays, gas-related symptoms, and preserving physiological functions such as belching and vomiting. These findings support the role of MSA as a viable alternative to LF, but further randomized controlled trials are needed to strengthen the evidence base and assist clinicians in tailored decision-making.
- 29 September 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 585
Single-session bilateral vs. staged unilateral renal stone removal: comparative outcomes in a systematic review and meta-analysis
There is still controversy regarding the best approach to bilateral renal urolithiasis. Single-session bilateral (SSB) renal stone removal is considered superior due to fewer procedures and less anesthesia exposure. However, doubts persist about its effectiveness and safety compared to staged unilateral (SU) procedures, particularly concerning complications and stone-free rates (SFR). We conducted a systematic review and meta-analysis to compare outcomes of these approaches. We hypothesize that SSB procedures have similar outcomes in terms of complications and SFR with fewer interventions. A meta-analysis following Cochrane and PRISMA guidelines included studies from 2002 to 2024 comparing SSB to SU procedures. Searches were conducted in PubMed, Cochrane, and EMBASE, focusing on complication rates, SFR, operative time, and additional procedures. The search yielded 13 studies with a total of 836,414 patients, of which 7,854 were in the SSB group. The rate of severe complications (Clavien-Dindo grade ≥ 3) was not significantly different between SSB versus SU groups (RR 1.22; 95% CI 0.65-2.26; P = 0.53). Nevertheless, overall complication rates were notably higher for SSB procedures (RR 1.32; 95% CI 1.08-1.62; P = 0.007). SFR was similar between approaches (RR 0.89; 95% CI 0.74-1.07; P = 0.23). Importantly, SSB procedures resulted in significantly longer operative times (MD 27.93 minutes; 95% CI 7.78-48.07; P = 0.007) and had a significantly higher need for unplanned additional interventions (RR 1.65; 95% CI 1.44-1.89; P < 0.00001).The search yielded 13 studies with a total of 836,414 patients, of which 7,854 were in the SSB group. The rate of severe complications (Clavien-Dindo grade ≥ 3) was not significantly different between SSB versus SU groups (RR 1.22; 95% CI 0.65-2.26; P = 0.53). Nevertheless, overall complication rates were notably higher for SSB procedures (RR 1.32; 95% CI 1.08-1.62; P = 0.007). SFR was similar between approaches (RR 0.89; 95% CI 0.74-1.07; P = 0.23). Importantly, SSB procedures resulted in significantly longer operative times (MD 27.93 minutes; 95% CI 7.78-48.07; P = 0.007) and had a significantly higher need for unplanned additional interventions (RR 1.65; 95% CI 1.44-1.89; P < 0.00001). SSB procedures achieve similar SFR and severe complication rates as SU procedures but involve longer operative times and higher overall complication rates. Their advantage lies in reducing planned surgical sessions, offering fewer anesthesia exposures, though this benefit is offset by an increased need for unplanned additional procedures.
- 29 September 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 585
Single-session bilateral vs. staged unilateral renal stone removal: comparative outcomes in a systematic review and meta-analysis
There is still controversy regarding the best approach to bilateral renal urolithiasis. Single-session bilateral (SSB) renal stone removal is considered superior due to fewer procedures and less anesthesia exposure. However, doubts persist about its effectiveness and safety compared to staged unilateral (SU) procedures, particularly concerning complications and stone-free rates (SFR). We conducted a systematic review and meta-analysis to compare outcomes of these approaches. We hypothesize that SSB procedures have similar outcomes in terms of complications and SFR with fewer interventions. A meta-analysis following Cochrane and PRISMA guidelines included studies from 2002 to 2024 comparing SSB to SU procedures. Searches were conducted in PubMed, Cochrane, and EMBASE, focusing on complication rates, SFR, operative time, and additional procedures. The search yielded 13 studies with a total of 836,414 patients, of which 7,854 were in the SSB group. The rate of severe complications (Clavien-Dindo grade ≥ 3) was not significantly different between SSB versus SU groups (RR 1.22; 95% CI 0.65-2.26; P = 0.53). Nevertheless, overall complication rates were notably higher for SSB procedures (RR 1.32; 95% CI 1.08-1.62; P = 0.007). SFR was similar between approaches (RR 0.89; 95% CI 0.74-1.07; P = 0.23). Importantly, SSB procedures resulted in significantly longer operative times (MD 27.93 minutes; 95% CI 7.78-48.07; P = 0.007) and had a significantly higher need for unplanned additional interventions (RR 1.65; 95% CI 1.44-1.89; P < 0.00001).The search yielded 13 studies with a total of 836,414 patients, of which 7,854 were in the SSB group. The rate of severe complications (Clavien-Dindo grade ≥ 3) was not significantly different between SSB versus SU groups (RR 1.22; 95% CI 0.65-2.26; P = 0.53). Nevertheless, overall complication rates were notably higher for SSB procedures (RR 1.32; 95% CI 1.08-1.62; P = 0.007). SFR was similar between approaches (RR 0.89; 95% CI 0.74-1.07; P = 0.23). Importantly, SSB procedures resulted in significantly longer operative times (MD 27.93 minutes; 95% CI 7.78-48.07; P = 0.007) and had a significantly higher need for unplanned additional interventions (RR 1.65; 95% CI 1.44-1.89; P < 0.00001). SSB procedures achieve similar SFR and severe complication rates as SU procedures but involve longer operative times and higher overall complication rates. Their advantage lies in reducing planned surgical sessions, offering fewer anesthesia exposures, though this benefit is offset by an increased need for unplanned additional procedures.
- Open Access
- 1 September 2024
- Published by Georg Thieme Verlag KG in Revista Brasileira de Cirurgia Plástica (RBCP) – Brazilian Journal of Plastic Surgery
- Vol. 39 (03) , 001-006
Câncer de pele não melanoma: Um estudo sobre o perfil epidemiológico e fluxo no HC-UFMG
▪ RESUMO: Os carcinomas de queratinócitos, basocelular e espinocelular, são os principais tipos de câncer de pele não melanoma (CPNM). Embora não representem um alto risco de mortalidade, essas neoplasias têm um impacto significativo na saúde pública, causando prejuízos estéticos e funcionais, principalmente em áreas constantemente expostas ao sol, como a cabeça, pescoço e face. A cirurgia é uma abordagem estabelecida no tratamento do CPNM. O presente estudo tem como objetivo traçar um perfil epidemiológico dos pacientes submetidos à cirurgia para o tratamento de CPNM pelo serviço de cirurgia plástica do Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG).Realizou-se um estudo epidemiológico descritivo no Ambulatório Borges da Costa do Hospital das Clínicas da UFMG, entre março e agosto de 2023. Um formulário foi desenvolvido para a coleta de dados, abrangendo variáveis relevantes para a análise epidemiológica.A amostra de 26 pacientes apresentou uma média de idade de 69 anos, com predominância de pacientes brancos (88,4%). As lesões foram mais frequentes no nariz (53,8%), terço médio lateral da face (20,5%), e frontal (12,8%). Quanto à margem, 55,8% vieram com margens livres, 41,1% comprometidas e 2,9% com margens exíguas.Os resultados destacam a necessidade de sistematização do fluxo assistencial para pacientes com CPNM, visando uma compilação e avaliação mais eficaz. Além disso, as peculiaridades epidemiológicas dos pacientes atendidos puderam ser identificadas e avaliadas através do formulário proposto, fornecendo insights para melhorias no atendimento e na gestão do câncer de pele não melanoma no hospital.
- 1 September 2024
- Published by Georg Thieme Verlag KG in Revista Brasileira de Cirurgia Plástica (RBCP) – Brazilian Journal of Plastic Surgery
- Vol. 39 (03) , 001-006
Open AccessCâncer de pele não melanoma: Um estudo sobre o perfil epidemiológico e fluxo no HC-UFMG
▪ RESUMO: Os carcinomas de queratinócitos, basocelular e espinocelular, são os principais tipos de câncer de pele não melanoma (CPNM). Embora não representem um alto risco de mortalidade, essas neoplasias têm um impacto significativo na saúde pública, causando prejuízos estéticos e funcionais, principalmente em áreas constantemente expostas ao sol, como a cabeça, pescoço e face. A cirurgia é uma abordagem estabelecida no tratamento do CPNM. O presente estudo tem como objetivo traçar um perfil epidemiológico dos pacientes submetidos à cirurgia para o tratamento de CPNM pelo serviço de cirurgia plástica do Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG).Realizou-se um estudo epidemiológico descritivo no Ambulatório Borges da Costa do Hospital das Clínicas da UFMG, entre março e agosto de 2023. Um formulário foi desenvolvido para a coleta de dados, abrangendo variáveis relevantes para a análise epidemiológica.A amostra de 26 pacientes apresentou uma média de idade de 69 anos, com predominância de pacientes brancos (88,4%). As lesões foram mais frequentes no nariz (53,8%), terço médio lateral da face (20,5%), e frontal (12,8%). Quanto à margem, 55,8% vieram com margens livres, 41,1% comprometidas e 2,9% com margens exíguas.Os resultados destacam a necessidade de sistematização do fluxo assistencial para pacientes com CPNM, visando uma compilação e avaliação mais eficaz. Além disso, as peculiaridades epidemiológicas dos pacientes atendidos puderam ser identificadas e avaliadas através do formulário proposto, fornecendo insights para melhorias no atendimento e na gestão do câncer de pele não melanoma no hospital.